Emapalumab-lzsg and Irinotecan liposome Intravenous
Determining the interaction of Emapalumab-lzsg and Irinotecan liposome Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emapalumab
Brand name: Gamifant
Synonyms: Emapalumab
Generic Name: irinotecan liposomal
Brand name: Onivyde
Synonyms: Irinotecan liposomal, Irinotecan (Liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emapalumab-lzsg-Iron 100/C
- Emapalumab-lzsg-Iron 21/7
- Emapalumab-lzsg-Iron and Docusate
- Emapalumab-lzsg-Iron and Folic Acid
- Emapalumab-lzsg-Iron and Vitamin C
- Emapalumab-lzsg-Iron Chewable Tablets
- Irinotecan liposome Intravenous-Embeda
- Irinotecan liposome Intravenous-Embeline
- Irinotecan liposome Intravenous-Embeline (Clobetasol Cream, Gel, and Ointment)
- Irinotecan liposome Intravenous-Embeline (Clobetasol Solution)
- Irinotecan liposome Intravenous-Embeline E
- Irinotecan liposome Intravenous-Embeline Scalp Application